Thus, studies that combine clinical screening of obese patients and investigation of the functional defects of the obesity-linked MC4R variants can identify specific ways to correct these defects and are the first steps towards personalized medicine. The gene discussed is MC4R; the disease is obesity due to melanocortin 4 receptor deficiency.